Who we work with
- Patients seeking a molecularly informed treatment plan
- Patients and families seeking a second opinion
- Referring oncologists with complex molecular reports
- International patients consulting remotely
About the institute
We don't simply treat the name of the cancer. We seek to understand the biology behind it.
Dr AV Institute of Personalized Cancer Treatment and Research was established in 2021 in Gurgaon, Haryana, with a focus on Precision Oncology, molecular oncology and personalized cancer treatment.
Purpose
Empowering Precision Oncology for All.
Molecular medicine should not be reserved for a small number of patients in a small number of places. The institute exists to make a molecularly informed approach to cancer care accessible, carefully applied and honestly explained.
Our philosophy
Science first. Patient always.
Evidence
Decisions are grounded in the best available clinical and scientific evidence, including an honest account of what the evidence does not yet show.
Individual Biology
Molecular information may add insight into the biology of an individual cancer, and is used where it can realistically influence care.
Human Judgement
Data and computational tools support clinicians. Decisions belong to the clinician and the patient.
What we do
Clinical care, molecular diagnostics and research.
Precision Oncology consultation, molecular profiling, liquid biopsy, molecular tumor board review, cancer second opinions and translational research. See all services.
What we are careful not to claim
No outcome statistics, survival figures or success rates appear on this website. Molecular testing does not guarantee an actionable finding, and an actionable finding does not guarantee a response to treatment.
Faculty & clinical team
Who is involved in care.
Care at the Institute is led by Dr Amit Verma, Founder and Director, working with a clinical team assembled around each patient's needs.
Dr Amit Verma
Founder & Director
Dr Amit Verma founded the Institute in 2021 and leads consultation, molecular interpretation and treatment planning. His training spans AIIMS New Delhi and centres in the United States and Europe.
Medical Oncology, Molecular and Precision Oncology
- MBBS
- Residency (MD) — Biochemistry / Cancer Medicine, AIIMS, New Delhi
- MRCP (UK)
- ESMO certification in Medical Oncology
The wider team
Care is coordinated around each patient, bringing together the clinical and supportive expertise relevant to their needs.
- Oncology nursing for day care and infusion monitoring
- Home care nursing and coordination
- Molecular diagnostics and pathology partners
- Counselling and supportive care input
- Multidisciplinary input through Molecular Tumor Board discussion
Partners & collaborations
How the Institute works with others.
Precision oncology depends on laboratories, hospitals, academic groups and referring clinicians working together. The Institute collaborates across these areas rather than operating in isolation.
Diagnostic laboratories
Molecular, genomic and pathology testing is performed through accredited laboratory partners, selected according to the clinical question and the sample available.
Hospitals and treatment centres
Where admission, surgery, radiotherapy or cellular therapy delivery is required, care is coordinated with the appropriate centre.
Referring clinicians
Referred patients remain under the care of their referring clinician, with findings and recommendations shared back after review.
Academic and research groups
Research collaboration focuses on questions arising in clinic — biomarkers, molecular monitoring and translational work.
Collaboration guided by clinical need
The Institute works across appropriate diagnostics, clinical care and research-led collaboration according to each patient’s needs.
Understanding the biology may help make care more precise.
Consultations and second opinions are available in person and remotely.